Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Phosphatase and actin regulator 4 (PHACTR4) is a member of the Phactr family of proteins, which bind both protein phosphatase 1 (PP1) and actin[1][4][5]. PHACTR4 regulates PP1 activity and cytoskeletal dynamics by interacting with actin and targeting PP1 towards specific substrates, thereby modulating cellular functions including neural tube closure, cell migration, and proliferation[1][5][6]. PHACTR4 acts as a tumor suppressor by restraining normal cell proliferation and transformation, in part through regulation of the Rb pathway and dephosphorylation of PP1 substrates; its loss through mutation or deletion is observed in multiple human cancers[6][7]. Beyond cancer, it is essential for neural development; mutations can cause neurodevelopmental defects such as neural tube and optic fissure closure anomalies[5][7]. PHACTR4 also binds intermediate filament proteins in neural cells and its activity is modulated by protein phosphorylation[3]. No drugs directly targeting PHACTR4 are currently known, and there are no established drug mechanisms, biomarkers, or specific safety liabilities documented beyond its essential developmental and tumor suppressor roles[5][6][7].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Phosphatase and actin regulator 4 (PHACTR4).